Ethyl 5-aminobenzo[b]furan-2-carboxylate

We are Ethyl 5-aminobenzo[b]furan-2-carboxylate CAS:174775-48-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:   Ethyl 5-aminobenzo[b]furan-2-carboxylate
CAS.NO:174775-48-5
Synonyms:
Ethyl 5-Aminobenzofuran-2-Carboxylate
Ethyl 5-amino-1-benzofuran-2-carboxylate

Molecular Formula:C11H11NO3
Molecular Weight:205.21000

Physical and Chemical Properties:
Density: 1.258g / cm3
Boiling point: 348.1ºC at 760mmHg
Melting point: 54-56ºC
Flash point: 164.3ºC
Refractive index: 1.617

Specification:
Appearance: White Crystal Solid
Purity:≥98%
Total ImpurityL:≤2.0%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Refrigerator.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Veratrazodone hydrochloride CAS:163521-08-2
Intermediates of Vilazodone CAS:163521-12-8

Related News: At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.Ácido 4- (metilsulfonil) fenilborónico CAS:149104-88-1 At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.1218-69-5 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.2-Ethyl-6-methylaniline CAS:24549-06-2 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.